Ken Sansone – Advisory Board Member
Ken is currently President at Bridge Clinical Solutions, a clinical development consulting company. With over 40 years of research experience, Ken has close to 30 years of those years in contributions for Global Clinical Development roles, working with pharmaceutical, medical device and biotech firms.
Professional experience includes Senior Director of Project Management at BioMarin Pharmaceutical, where he had leadership roles for several important phase 1-4 projects. Ken also has had key roles with Berlex/Bayer, Medtronic, and during over 10 years of varied clinical consulting roles with companies including Novartis, Ultragenyx, Eloxx, Ipsen, and DSP Clinical Research, among others. Ken has also developed on-line course content and worked as an instructor in UC Berkeley’s Extension Program for Clinical Research Conduct and Management. Ken specializes in Rare and Ultra-rare diseases and has deep and diverse experience in all phases of Clinical Development including clinical strategy, project and program management, protocol development and execution, GCP auditing, and training.
Ken received his BS in Biology from Delaware Valley University, with post-graduate work in Human Physiology and Biochemistry at Rutgers University.